0001753939-19-000001.txt : 20190117
0001753939-19-000001.hdr.sgml : 20190117
20190117162605
ACCESSION NUMBER: 0001753939-19-000001
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190115
FILED AS OF DATE: 20190117
DATE AS OF CHANGE: 20190117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Teague Robert Eric
CENTRAL INDEX KEY: 0001753939
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-13789
FILM NUMBER: 19531206
MAIL ADDRESS:
STREET 1: C/O MARINA BIOTECH, INC.
STREET 2: 4721 EMPEROR BOULEVARD, SUITE 350
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adhera Therapeutics, Inc.
CENTRAL INDEX KEY: 0000737207
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 112658569
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4721 EMPEROR BOULEVARD
STREET 2: SUITE 350
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-578-5901
MAIL ADDRESS:
STREET 1: 4721 EMPEROR BOULEVARD
STREET 2: SUITE 350
CITY: DURHAM
STATE: NC
ZIP: 27703
FORMER COMPANY:
FORMER CONFORMED NAME: Marina Biotech, Inc.
DATE OF NAME CHANGE: 20100722
FORMER COMPANY:
FORMER CONFORMED NAME: MDRNA, Inc.
DATE OF NAME CHANGE: 20080610
FORMER COMPANY:
FORMER CONFORMED NAME: NASTECH PHARMACEUTICAL CO INC
DATE OF NAME CHANGE: 19920703
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-01-15
0
0000737207
Adhera Therapeutics, Inc.
ATRX
0001753939
Teague Robert Eric
C/O ADHERA THERAPEUTICS, INC.
4721 EMPEROR BOULEVARD, SUITE 350
DURHAM
NC
27703
0
1
0
0
Chief Financial Officer
Options to purchase common stock
0.32
2019-01-15
4
A
0
100000
0
A
2029-01-15
common stock
100000
100000
D
Options to purchase 25,000 shares of common stock are exercisable immediately, and options to purchase 25,000 shares of common stock shall vest on each of the one, two and three year anniversaries of the grant date.
/s/ R. Eric Teague
2019-01-17